News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
BMS and Century Therapeutics Will Combine Cell Therapy Forces Against Cancer
Century Therapeutics and Bristol Myers Squibb (BMS) are collaborating on four programs for hematologic malignancies and tumors. BMS, which has a presence in Seattle, will
Absci announces new and expanded collaboration with Merck
Absci, a Washington-based life science company has announced a collaboration with Merck worth up to $610 million in milestone payments and upfront fees. Under the
To fight opioid crisis, UW researchers take new shot at developing vaccine against addictive drugs
The University of Washington has officially opened the Center for Medication Development for Substance Use Disorders after raising more than $2 million in funding. Researchers
Good Therapeutics lands $8M to develop protein drugs that work only where needed in the body
Good Therapeutics, a Seattle startup, has raised $8 million toward advancing therapeutic proteins aimed at helping cancer patients. With 22 employees total, the company is
Seattle stem cell startup lands $10M to speed development of its drug discovery platforms
After announcing it was raising a $6 million Series A last March, Curi Bio Inc., a Seattle life science startup has closed a $10 million
Bristol Myers Squibb exec on the company’s growth in Seattle and beating cancer with immune cells
Since acquiring Celgene and its Seattle operations a couple years ago, Bristol Meyers Squibb (BMS) has been growing its presence in the Seattle area. Now,